When asked about the drugs on McDonald's earnings conference call last month, CEO Chris Kempczinski touted the burger chain's existing protein options
GLP-1 receptor agonists like semaglutide have demonstrated sustained weight loss of 15-22% in clinical trials, yet many Americans struggle to access them through traditional insurance channels
For Somers, it's not about the glamor of it all
Rybelsus: Weight Management Potential Although Rybelsus is primarily focused on glycemic control, it has shown some potential in aiding weight loss
Remember that semaglutide side effects are normal, expected, and manageable
What to Expect If Youre Exploring Peptide Therapy Even though Retatrutide isnt available outside of clinical trials yet, it represents a new wave of treatments that target multiple systems in the body at once